Triethylamine → N-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-2-pyridin-2-ylacetamide
反応式
CC1(C)C[CH:10]([NH2:12])[C:9]2[C:4](=[CH:5][CH:6]=[CH:7]C=2)[O:3]1.[N:14]1[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=1[CH2:20][C:21]([OH:23])=O.CCN=C=NCCCN(C)C.[ClH:35].[CH:36]1[CH:37]=[CH:38][C:39]2N(O)N=N[C:40]=2[CH:41]=1.C(N(CC)CC)C>ClCCl>[Cl:35][C:36]1[CH:41]=[C:40]2[C:39](=[CH:38][CH:37]=1)[O:3][C:4]1([CH2:5][CH2:6][CH2:7]1)[CH2:9][CH:10]2[NH:12][C:21](=[O:23])[CH2:20][C:15]1[CH:16]=[CH:17][CH:18]=[CH:19][N:14]=1参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
The title compound was prepared from Intermediate 2 (200 mg, 0.898 mmol) and 2-pyridylacetic acid (234 mg, 1.348 mmol) in presence of EDCI.HCl (258 mg, 1.348 mmol), HOBt (206 mg, 1.348 mmol) and triethylamine (375 μl, 2.696 mmol) in dichloromethane (10 ml) as described in Example 1 to give 151 mg of the product as a white solid; IR (KBr) 3272, 2936, 1644, 1477, 1265, 812 cm−1; 1H NMR (300 MHz, DMSO-d6) δ 1.65-1.88 (m, 3H), 2.02-2.20 (m, 3H), 2.25-2.35 (m, 2H), 3.71 (q, J=12.0 Hz, 2H), 5.00-5.15 (m, 1H), 6.73 (t, J=7.8 Hz, 1H), 6.76 (d, J=8.4 Hz, 1H), 7.10-7.20 (m, 2H), 7.22-7.30 (m, 1H), 7.70-7.80 (m, 1H), 8.49 (s, 1H), 8.62 (d, J=8.4 Hz, 1H); ESI-MS (m/z) 343.21 (M+H)+.
出典と根拠
- ORDレコード
- ord-6cdbf3dfb03d4735b1565795d6602ff2
- 出典データセット
- uspto-grants-2013_07
- 特許番号
- US08487121B2
反応ノート
読み込み中…